Newsroom

Press Release - All

• 09 Feb 2023
  Agilent Announces New NovoCyte Flow Cytometer System Software for 21 CFR Part 11 Compliance
• 30 Jan 2023
  Agilent to Announce First-Quarter Fiscal Year 2023 Financial Results Feb. 28
• 23 Jan 2023
  Agilent to Collaborate with Quest Diagnostics to Extend Access to the Agilent Resolution ctDx FIRST Liquid Biopsy Test
• 18 Jan 2023
  Agilent Included in Just Capital’s 2023 List of Most Just Companies
• 09 Jan 2023
  Agilent Investing $725 Million to Expand State-of-the-Art Manufacturing Capacity for Production of Nucleic Acid-Based Therapeutics
• 09 Jan 2023
  Agilent Authorizes $2 Billion Share Repurchase Program
• 06 Jan 2023
  Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications
• 04 Jan 2023
  Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
• 16 Dec 2022
  Agilent to Present at Goldman Sachs and J.P. Morgan Healthcare Conferences
• 12 Dec 2022
  Agilent Resolution ctDx FIRST Receives FDA Approval as a Liquid Biopsy Companion Diagnostic Test for Advanced Non-small Cell Lung Cancer